冠状动脉药物涂层支架后再狭窄与炎症反应的相关性  

Relationship Between Restenosis After Implantation of Drug-eluting Stent and Inflammatory Reaction

作　　者：杜健鹏[1] 史大卓[2] 

机构地区：[1]中国中医科学院,2007级博士北京100091 [2]中国中医科学院西苑医院,北京100091

出　　处：《心血管病学进展》2009年第5期791-794,共4页Advances in Cardiovascular Diseases

摘　　要：药物涂层支架的应用使冠心病的介入治疗有了长足进展,但是支架再狭窄仍是不容忽视的问题。现就支架后的炎症反应和再狭窄的关系,药物涂层支架对于抑制炎症和降低再狭窄发生率的作用机理进行综述。Since the introduction of the bare-metal stent, the drug-eluting stent has made major developments in percutaneous coronary intervention in the treatment of obstructive coronary artery disease. However, long term success of percutaneous coronary intervention is in- hibited by neointimal hyperplasia occurring within the stent leading to in-stent restenosis. This article reviews the relationship between in- stent restenosis and the inflammatory reaction after stenting, and the mechanism for the drug-eluting stent to inhibit the inflammation and de- crease the rate of in-stent restcnosis.

关 键 词：经皮冠状动脉介入术 药物涂层支架 再狭窄 炎症反应 

分 类 号：R541.4[医药卫生—心血管疾病] R816.2[医药卫生—内科学]